Semaglutide is a long-acting GLP-1 (glucagon-like peptide-1) receptor agonist. It is one of the most extensively studied incretin-mimetic peptides in metabolic research.
Studied for: glucose-dependent insulin secretion, GLP-1 receptor signalling, appetite and food-intake regulation, and energy metabolism in research settings.
Presentation: supplied as a 10mg lyophilised powder vial.
Purity: ≥99% (HPLC verified).
Supplied as a lyophilised powder requiring reconstitution with bacteriostatic water prior to use in research.
For research purposes only. Not for human or animal consumption. Not a medicinal product.
Reviews
There are no reviews yet.